Indication
Polio
5 clinical trials
7 products
Clinical trial
A Multi-country, Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial to Evaluate the Immunogenicity and Tolerability of Sabin Strain Inactivated Poliovirus Vaccine Administered With or Without Routine Infant VaccinesStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
Immune Response to Pertussis After Vaccination With a Tdap-IPV Booster Vaccine in Children in the Republic of South Africa: Effect of Homologous and Heterologous Pertussis Vaccination Priming BackgroundStatus: Completed, Estimated PCD: 2023-01-11
Clinical trial
Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), Bivalent Oral Poliovirus Vaccine (bOPV) and Inactivated Poliovirus Vaccine (IPV) Administered With Different Sequential or Combination SchedulesStatus: Not yet recruiting, Estimated PCD: 2024-06-01
Product
Polio VaccinesClinical trial
Clinical Trial to Compare the Immunogenicity of the Inactivated Poliovirus Vaccine (IPV) Administered in Reduced Doses Intramuscularly or Intradermally in Infants at 2 and 4 Months of Age in the Maputo CityStatus: Completed, Estimated PCD: 2022-05-31
Clinical trial
Phase IV Study of Evaluating Immunogenicity and Safety of Concomitant Administration of Sabin-strain-based Inactivated Poliovirus Vaccine (Vero Cells) and Freeze-dried Live-attenuated Hepatitis A Vaccine or Inactivated Hepatitis A VaccineStatus: Not yet recruiting, Estimated PCD: 2026-08-15
Product
sIPVProduct
HepA-LProduct
HepA-I